-
CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY
16 Jul 2025 13:00 GMT
… changes to relationships with customers, employees, suppliers or other parties resulting … request to Cyclacel Pharmaceuticals, Inc., at ir@cyclacel.com. Contacts Cyclacel Pharmaceuticals, Inc.
Datuk …
-
CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT
07 Jul 2025 10:00 GMT
… changes to relationships with customers, employees, suppliers or other parties resulting … request to Cyclacel Pharmaceuticals, Inc., at ir@cyclacel.com. Contacts Cyclacel Pharmaceuticals, Inc.
Datuk …
-
CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN. BHD. ITS WHOLLY-OWNED SUBSIDIARY TO ACCELERATE GROWTH AND STOCKHOLDER VALUE
06 May 2025 10:00 GMT
… members of their management and employees, may, under SEC rules, … therefrom. For further information contact: Cyclacel Pharmaceuticals, Inc.
Datuk Dr. Doris … Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc.
-
Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study
25 Sep 2024 13:15 GMT
… 2 part of the study employs a Simon 2-stage design … or otherwise. Contact © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The … and Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc. ______________________________
1 www.cbioportal …
-
Teva to divest business venture in Japan; Layoffs at Rome Therapeutics
06 Dec 2024 18:13 GMT
Plus, news about Cyclacel Pharmaceuticals, MediciNova and Revolution Medicines:
Teva will divest its Japan business venture to private equity firm: The company
Sign up to read this article for free.
Get free access to a limited …
-
Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer
30 Jan 2024 14:15 GMT
… Kirschbaum, M.D., whose employment was terminated by the Company … prior to his career in the biopharmaceutical industry. About Cyclacel Pharmaceuticals, Inc.
… or otherwise. Contacts © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. …
-
Adrenocortical Carcinoma Market Forecast upto 2034—Insights into Emerging Therapies and Market Trends | DelveInsight
29 Jul 2025 17:00 GMT
… , cisplatin, and mitotane) is often employed. Patients with less aggressive disease … including Corcept Therapeutics, Crinetics Pharmaceuticals, Cyclacel Pharmaceuticals, Sparrow Pharmaceuticals, Stero Therapeutics, among …
-
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q4 2022 Earnings Call Transcript
09 Mar 2023 03:48 GMT
… afternoon and welcome to the Cyclacel Pharmaceuticals Fourth Quarter and Full … due to an increase in employment and professional costs. Total other … ;A Session
Follow Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) Follow Cyclacel Pharmaceuticals Inc. (NASDAQ: …
-
Cyclacel Pharmaceuticals Reports Fourth Quarter And Full Year 2022 Financial Results And Provides Business Update
06 Mar 2023 21:05 GMT
… increase in employment and professional … of Cyclacel Pharmaceuticals, Inc. SOURCE: Cyclacel Pharmaceuticals, Inc. CYCLACEL PHARMACEUTICALS, INC … ,926,173
CYCLACEL PHARMACEUTICALS, INC.
CONSOLIDATED BALANCE SHEET
(In …
-
Unity Layoffs 2024: What to Know About the Latest U Job Cuts
09 Jan 2024 15:15 GMT
… layoffs will see roughly 1,800 Unity employees lose their jobs as … charges connected to these layoffs but doesn’t have … were previous layoffs that affected 600 Unity employees in July … on with shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC), Grifols (NASDAQ …
About
© 1995-2025